ALAN HANLEY: Open Payments
NPI 1750442166 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,961 in 107 payments from 18 companies in 2025. Trend: 2023 $2,075 · 2024 $1,999 · 2025 $1,961
Food & beverage: $1,961
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $382 |
| GlaxoSmithKline, LLC. | 16 | $277 |
| Novo Nordisk Inc | 12 | $259 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $176 |
| PFIZER INC. | 14 | $162 |
| ABBVIE INC. | 7 | $156 |
| Exact Sciences Corporation | 7 | $122 |
| Amgen Inc. | 5 | $92 |
| Paratek Pharmaceuticals, Inc. | 5 | $86 |
| Dexcom, Inc. | 3 | $62 |
Products named: TRELEGY ELLIPTA, FARXIGA, Kerendia, Ozempic, Cologuard Collection Kit, NURTEC ODT, UBRELVY, Rybelsus.
Industry payments across AL — which companies pay providers there.
